Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001641172-25-011942
Filing Date
2025-05-21
Accepted
2025-05-21 17:29:45
Documents
16
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A form10-ka.htm   iXBRL 10-K/A 646775
2 EX-31.1 ex31-1.htm EX-31.1 18398
3 EX-31.2 ex31-2.htm EX-31.2 18367
4 EX-32.1 ex32-1.htm EX-32.1 11272
  Complete submission text file 0001641172-25-011942.txt   1024361

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE celu-20241231.xsd EX-101.SCH 3867
6 XBRL DEFINITION FILE celu-20241231_def.xml EX-101.DEF 27562
7 XBRL LABEL FILE celu-20241231_lab.xml EX-101.LAB 38178
8 XBRL PRESENTATION FILE celu-20241231_pre.xml EX-101.PRE 26180
18 EXTRACTED XBRL INSTANCE DOCUMENT form10-ka_htm.xml XML 10086
Mailing Address 170 PARK AVE FLORHAM PARK NJ 07932
Business Address 170 PARK AVE FLORHAM PARK NJ 07932 (908) 768-2170
Celularity Inc (Filer) CIK: 0001752828 (see all company filings)

EIN.: 831702591 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-38914 | Film No.: 25974143
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)